137 related articles for article (PubMed ID: 8652141)
1. Budesonide or prednisolone in active Crohn's disease.
Baert F; Rutgeerts P
Ann Med; 1995 Dec; 27(6):631. PubMed ID: 8652141
[No Abstract] [Full Text] [Related]
2. Oral budesonide is as effective as oral prednisolone in active Crohn's disease. The Global Budesonide Study Group.
Campieri M; Ferguson A; Doe W; Persson T; Nilsson LG
Gut; 1997 Aug; 41(2):209-14. PubMed ID: 9301500
[TBL] [Abstract][Full Text] [Related]
3. Budesonide in the management of patients with Crohn's disease.
Thomson AB; Sadowski D; Jenkins R; Wild G
Can J Gastroenterol; 1997 Apr; 11(3):255-60. PubMed ID: 9167034
[TBL] [Abstract][Full Text] [Related]
4. A comparison of budesonide with prednisolone for active Crohn's disease.
Rutgeerts P; Löfberg R; Malchow H; Lamers C; Olaison G; Jewell D; Danielsson A; Goebell H; Thomsen OO; Lorenz-Meyer H
N Engl J Med; 1994 Sep; 331(13):842-5. PubMed ID: 8078530
[TBL] [Abstract][Full Text] [Related]
5. Budesonide. A review of its pharmacological properties and therapeutic efficacy in inflammatory bowel disease.
Spencer CM; McTavish D
Drugs; 1995 Nov; 50(5):854-72. PubMed ID: 8586030
[TBL] [Abstract][Full Text] [Related]
6. Controlled-release budesonide in Crohn's disease.
Drug Ther Bull; 1997 Apr; 35(4):30-1. PubMed ID: 9282408
[TBL] [Abstract][Full Text] [Related]
7. Budesonide versus prednisolone for the treatment of active Crohn's disease in children: a randomized, double-blind, controlled, multicentre trial.
Escher JC;
Eur J Gastroenterol Hepatol; 2004 Jan; 16(1):47-54. PubMed ID: 15095852
[TBL] [Abstract][Full Text] [Related]
8. Oral budesonide in active Crohn's disease.
Löfberg R; Danielsson A; Salde L
Aliment Pharmacol Ther; 1993 Dec; 7(6):611-6. PubMed ID: 8161666
[TBL] [Abstract][Full Text] [Related]
9. Budesonide in glucocorticoid dependent chronic active Crohn's disease; a pilot study.
Novacek G; Kleinberger M; Vogelsang H; Moser G; Lochs H
Z Gastroenterol; 1995 May; 33(5):251-4. PubMed ID: 7610692
[TBL] [Abstract][Full Text] [Related]
10. Budesonide and prednisolone suppress peripheral blood natural killer cells in Crohn's disease.
Van Ierssel AJ; Van der Sluys Veer A; Verspaget HW; Griffioen G; Van Hogezand RA; Lamers CB
Aliment Pharmacol Ther; 1995 Apr; 9(2):173-8. PubMed ID: 7605858
[TBL] [Abstract][Full Text] [Related]
11. Severe hypokalemia after budesonide treatment for Crohn's disease.
Rosenbach Y; Zahavi I; Rachmal A; Dinari G
J Pediatr Gastroenterol Nutr; 1997 Mar; 24(3):352-5. PubMed ID: 9138184
[No Abstract] [Full Text] [Related]
12. Budesonide in inflammatory bowel disease.
Lamers CB; Wagtmans MJ; van der Sluys Veer A; van Hogezand RA; Griffioen G
Neth J Med; 1996 Feb; 48(2):60-3. PubMed ID: 8819801
[TBL] [Abstract][Full Text] [Related]
13. Treatment of active and postactive ileal and colonic Crohn's disease with oral pH-modified-release budesonide. German Budesonide Study Group.
Caesar I; Gross V; Roth M; Andus T; Schmidt C; Raedsch R; Weber A; Gierend M; Ewe K; Schölmerich J
Hepatogastroenterology; 1997; 44(14):445-51. PubMed ID: 9164517
[TBL] [Abstract][Full Text] [Related]
14. Budesonide for inflammatory bowel disease. Is it a magic bullet?
Sachar DB
N Engl J Med; 1994 Sep; 331(13):873-4. PubMed ID: 8078535
[No Abstract] [Full Text] [Related]
15. A comparison of budesonide and mesalamine for active Crohn's disease.
Lowry PW; Sandborn WJ
Gastroenterology; 1999 May; 116(5):1263. PubMed ID: 10220523
[No Abstract] [Full Text] [Related]
16. [Budesonide in acute attacks of Crohn disease of medium intensity].
Marteau P
Gastroenterol Clin Biol; 1995 Apr; 19(4):459-60. PubMed ID: 7672543
[No Abstract] [Full Text] [Related]
17. [Advances in the topical steroid treatment of inflammatory bowel diseases].
Díaz Blasco J; Robledo Andrés P
Rev Esp Enferm Dig; 1995 Nov; 87(11):802-7. PubMed ID: 8534536
[No Abstract] [Full Text] [Related]
18. [New therapeutic modalities in Crohn's disease].
Rachmilewitz D
Harefuah; 1999 Jun; 136(12):943-5. PubMed ID: 10955155
[No Abstract] [Full Text] [Related]
19. Contribution of plasma cortisol to corticosteroid-suppressed peripheral blood natural killer cell activity in Crohn's disease.
van Ierssel GJ; van der Sluys Veer A; Verspaget HW; Griffioen G; van Hogezand RA; Lamers CB
Immunopharmacology; 1995 Feb; 29(1):11-7. PubMed ID: 7768667
[TBL] [Abstract][Full Text] [Related]
20. Switch from systemic steroids to budesonide in steroid dependent patients with inactive Crohn's disease.
Cortot A; Colombel JF; Rutgeerts P; Lauritsen K; Malchow H; Hämling J; Winter T; Van Gossum A ; Persson T; Pettersson E
Gut; 2001 Feb; 48(2):186-90. PubMed ID: 11156638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
